Search Results 731-740 of 18306 for prostate cancer

  1. Men Ages 40-49 Could Skip Annual PSA Screening

    The study also found that participants with low PSAs, below 1.0 ng/ml, were also very unlikely to develop even low-risk prostate cancer. Soundbites with ...

  2. Research Tool Used in Prostate Cancer May Lead to New Therapies

    This tool, which was studied using prostate cancer animal and cell models, consists of human-made protein complexes, called "proteolysis-targeting chimeras," ...

  3. Differences In Immunological Effects Of Vitamin D Replacement Among African American Prostate Cancer Patients With Localized Versus Metastatic Disease - Mayo Clinic

    Also, we will evaluate whether the peripheral blood immune cell function is different in B/AA prostate cancer patients with metastatic disease as compared with ...

  4. A Study To Evaluate The Safety And Effectiveness Of Focal US-guided Cryo-ablation Using DynaCAD/UroNAV Preplanning - Mayo Clinic

    Participation eligibility · ASA status > 3. · Very Low Risk Prostate Cancer based on Epstein's Criteria having a tumor <0.2 cc (AUA Guidelines 2017 pg. · GG1, PSA ...

  5. Urology News - Medical Professionals - Mayo Clinic

    Metastatic castration-resistant prostate cancer presents treatment challenges, including the side effects of chemotherapy. Mayo Clinic researchers find that ...

  6. Treating male urinary incontinence using the artificial urinary sphincter - Mayo Clinic

    Prostate cancer and benign growth of the prostate are two very common conditions affecting thousands of men every year. Surgeons perform thousands of ...

  7. Evaluation Of Neuroendocrine Differentiation As A Potential Mechanism Of Tumor Recurrence Following Radiotherapy In Prostate Carcinoma - Mayo Clinic

    ... prostate cancer recurrence after RT. Serum CgA level is measured before the start of RT and/or the start of neoadjuvant ADT for patients undergoing a ...

  8. Darolutamide (oral route) - Side effects & dosage - Mayo Clinic

    Darolutamide is used to treat patients with non-metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical ...

  9. Brian J. Davis, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Prostate cancer radiotherapy innovation. Dr. Davis pioneers advanced imaging and ultrasound technologies to improve the precision of prostate cancer treatment.

  10. Breast cancer - Doctors and departments - Mayo Clinic

    for prostate cancer, Radiation therapy for prostate cancer, Intensity-modulated radiation therapy, 3D conformal radiotherapy, Breast cancer, Lung cancer ...